LIM kinases as new therapeutic targets for the treatment of neurofibromatosis type 1

A. Champiré , A. Braka (1) , B. Vallée (1) , M. Doudeau (1) , F. Godin (1) , K. Plé , S. Aci-Sèche (1) , S. Bourg (1) , Norbert Garnier (1) , H. Cubéros , S. Marouillat , R.-A. Thepault , P. Vour’ch , C. Andrés (2) , P. Castelnau , P. Bonnet (3) , S. Routier , H. Bénédetti (1)

1 CBM - Centre de biophysique moléculaire
2 UB - Université de Bourgogne
3 IMN - Institut des Matériaux Jean Rouxel

Domaines: Sciences du Vivant [q-bio]

A. Champiré, A. Braka, B. Vallée, M. Doudeau, F. Godin, et al.. LIM kinases as new therapeutic targets for the treatment of neurofibromatosis type 1. VII International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC) –, Aug 2017, Vienne, Austria. ⟨hal-02904794⟩